600276 恒瑞醫藥
按盤價 
39.210 +0.760 (+1.977%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.325 | 10.991 | 10.728 | 13.831 | 22.896 |
| 總資產報酬率 ROA (%) | 3.038 | 9.988 | 9.570 | 12.245 | 20.320 |
| 投入資產回報率 ROIC (%) | 3.230 | 10.648 | 10.332 | 13.551 | 22.683 | 邊際利潤分析 |
| 銷售毛利率 (%) | 84.279 | 84.552 | 83.612 | 85.556 | 87.926 |
| 營業利潤率 (%) | 27.278 | 21.516 | 19.327 | 18.007 | 25.265 |
| 息稅前利潤/營業總收入 (%) | 22.574 | 18.356 | 16.440 | 15.936 | 24.207 |
| 淨利潤/營業總收入 (%) | 22.801 | 18.746 | 17.932 | 17.309 | 22.747 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.465 | 98.683 | 88.905 | 92.080 | 93.577 |
| 價值變動淨收益/利潤總額(%) | 0.529 | -2.302 | 11.689 | 5.590 | 5.191 |
| 營業外收支淨額/利潤總額(%) | -8.885 | -5.202 | -3.615 | -4.445 | -1.618 | 償債能力分析 |
| 流動比率 (X) | 9.116 | 12.252 | 8.500 | 8.875 | 7.437 |
| 速動比率 (X) | 8.501 | 11.346 | 7.827 | 8.168 | 6.966 |
| 資產負債率 (%) | 8.417 | 6.284 | 9.341 | 9.409 | 11.352 |
| 帶息債務/全部投入資本 (%) | 3.699 | 0.972 | 4.048 | 1.586 | 1.043 |
| 股東權益/帶息債務 (%) | 2,590.723 | 10,140.508 | 2,350.520 | 6,155.215 | 9,435.026 |
| 股東權益/負債合計 (%) | 1,073.502 | 1,470.724 | 955.631 | 947.456 | 773.713 |
| 利息保障倍數 (X) | -9.109 | -8.756 | -7.428 | -12.216 | -36.941 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.178 | 87.444 | 89.038 | 67.442 | 64.771 |
| 存貨周轉天數 (天) | 218.940 | 243.282 | 250.552 | 201.115 | 181.944 |
| 備註： | 即時報價更新時間為 05/07/2024 12:14 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
